Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Comprehensive Pharmaceutical Services on Medication Safety in Gynaecological Oncology Chemotherapy Patients

NCT06826950 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06826950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06826950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Comprehensive Pharmaceutical Services on Medication Safety in Gynaecological Oncology Chemotherapy Patients
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Completed
Start date
October 8, 2024
Completion date
January 24, 2025
Enrollment
629 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gynaecological oncology, neoplasms